British regulators issued the alert for two versions of a jab given to millions of pensioners and pregnant women after ...

Guillain-Barre syndrome is a rare but serious condition which needs urgent treatment in hospital to prevent it progressing.

In its alert, the MHRA said: “Healthcare professionals should advise all recipients of Abrysvo and Arexvy that they should be ...

GSK specialty medicines grew YoY in Q1 2025, and it is now the main profit engine, offsetting the weakness in their vaccine ...

Stay updated with the latest stock market news and live updates. Get real-time insights on Sensex Today, Nifty Live, stock market today, IPO news and more on Business Standard.

Pending: A vacant office block in Maidenhead could be turned into a large self-storage facility. Eurasia House in Concorde ...

Board Meeting Intimation for Board Meeting Intimation - Rediff MoneyWiz, the personal finance service from Rediff.com equips the user with tools and information in the form of graphs, charts, expert ...

Gen Z's preference for convenient formats like gummies and effervescent powders, coupled with rising health awareness, is ...

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report ...

UBS analyst Colin White maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today. The company’s shares opened today at p1,385.00. Don’t Miss TipRanks’ Hal ...

A groundbreaking NHS therapy for myeloma uses a 'Trojan horse' approach to target cancer cells, offering longer remission, ...

In addition to Goldman Sachs, GlaxoSmithKline also received a Hold from Deutsche Bank ‘s Emmanuel Papadakis in a report issued on June 24. However, today, J.P. Morgan maintained a Sell rating on ...